{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:21:00Z","timestamp":1788373260239,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-024-01620-x","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T08:02:37Z","timestamp":1708675357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Utility of UV Signature Mutations in the Diagnostic Assessment of Metastatic Head and Neck Carcinomas of Unknown Primary"],"prefix":"10.1007","volume":"18","author":[{"given":"Karina Colossi","family":"Furlan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryoush","family":"Saeed-Vafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffani M.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Saller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana O.","family":"Tabbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Wenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Hernandez-Prera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"issue":"9","key":"1620_CR1","first-page":"e5552","volume":"11","author":"A Qaseem","year":"2019","unstructured":"Qaseem A, Usman N, Jayaraj JS, Janapala RN, Kashif T (2019) Cancer of unknown primary: a review on clinical guidelines in the development and targeted management of patients with the unknown primary site. Cureus 11(9):e5552","journal-title":"Cureus"},{"key":"1620_CR2","doi-asserted-by":"publisher","first-page":"593164","DOI":"10.3389\/fonc.2020.593164","volume":"10","author":"FJ Civantos","year":"2020","unstructured":"Civantos FJ, Vermorken JB, Shah JP, Rinaldo A, Su\u00e1rez C, Kowalski LP et al (2020) Metastatic squamous cell carcinoma to the cervical lymph nodes from an unknown primary Cancer: management in the HPV era. Front Oncol 10:593164","journal-title":"Front Oncol"},{"key":"1620_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.oraloncology.2018.11.020","volume":"88","author":"P Golusinski","year":"2019","unstructured":"Golusinski P, Di Maio P, Pehlivan B, Colley S, Nankivell P, Kong A et al (2019) Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck. Oral Oncol 88:145\u2013152","journal-title":"Oral Oncol"},{"issue":"29","key":"1620_CR4","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1200\/JCO.2015.61.0063","volume":"33","author":"TJ Galloway","year":"2015","unstructured":"Galloway TJ, Ridge JA (2015) Management of squamous Cancer metastatic to cervical nodes with an unknown primary site. J Clin Oncol off J Am Soc Clin Oncol 33(29):3328\u20133337","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"issue":"1","key":"1620_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hed.21898","volume":"35","author":"P Strojan","year":"2013","unstructured":"Strojan P, Ferlito A, Medina JE, Woolgar JA, Rinaldo A, Robbins KT et al (2013) Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck 35(1):123\u2013132","journal-title":"Head Neck"},{"issue":"1","key":"1620_CR6","first-page":"2","volume":"25","author":"L Calabrese","year":"2005","unstructured":"Calabrese L, Jereczek-Fossa BA, Jassem J, Rocca A, Bruschini R, Orecchia R et al (2005) Diagnosis and management of neck metastases from an unknown primary. Acta Otorhinolaryngol Ital Organo Uff Della Soc Ital Otorinolaringol E Chir Cerv-facc 25(1):2\u201312","journal-title":"Acta Otorhinolaryngol Ital Organo Uff Della Soc Ital Otorinolaringol E Chir Cerv-facc"},{"key":"1620_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.radonc.2021.01.028","volume":"157","author":"L Bauwens","year":"2021","unstructured":"Bauwens L, Baltres A, Fiani DJ, Zrounba P, Buiret G, Fleury B et al (2021) Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma. Radiother Oncol J Eur Soc Ther Radiol Oncol 157:122\u2013129","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"8","key":"1620_CR8","first-page":"436","volume":"260","author":"WJ Issing","year":"2003","unstructured":"Issing WJ, Taleban B, Tauber S (2003) Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Oto-Rhino-Laryngol off J Eur Fed Oto-Rhino-Laryngol soc EUFOS Affil Ger soc Oto-Rhino-Laryngol -. Head Neck Surg 260(8):436\u2013443","journal-title":"Head Neck Surg"},{"issue":"4","key":"1620_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1023\/A:1011129429499","volume":"12","author":"M Saghatchian","year":"2001","unstructured":"Saghatchian M, Fizazi K, Borel C, Ducreux M, Ruffl\u00e9 P, Le Chevalier T et al (2001) Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation \u2013 results of a prospective study. Ann Oncol 12(4):535\u2013540","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"1620_CR10","doi-asserted-by":"publisher","first-page":"i75","DOI":"10.1093\/annonc\/mdi804","volume":"16","author":"E Briasoulis","year":"2005","unstructured":"Briasoulis E, Tolis C, Bergh J, Pavlidis N, ESMO Guidelines Task Force (2005) ESMO Minimum Clinical recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP). Ann Oncol off J Eur Soc Med Oncol 16(Suppl 1):i75\u201376","journal-title":"Ann Oncol off J Eur Soc Med Oncol"},{"key":"1620_CR11","unstructured":"COSMIC database. Mutational Signatures (v2 - March 2015) [Internet]. Available from: https:\/\/cancer.sanger.ac.uk\/signatures\/signatures_v2\/"},{"issue":"1","key":"1620_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/php.12377","volume":"91","author":"DE Brash","year":"2015","unstructured":"Brash DE (2015) UV signature mutations. Photochem Photobiol 91(1):15\u201326","journal-title":"Photochem Photobiol"},{"issue":"1","key":"1620_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1073\/pnas.93.1.274","volume":"93","author":"RJ Berg","year":"1996","unstructured":"Berg RJ, van Kranen HJ, Rebel HG, de Vries A, van Vloten WA, Van Kreijl CF et al (1996) Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci U S A 93(1):274\u2013278","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1620_CR14","doi-asserted-by":"publisher","first-page":"E82","DOI":"10.1002\/hed.25613","volume":"41","author":"JW Chan","year":"2019","unstructured":"Chan JW, Yeh I, El-Sayed IH, Algazi AP, Glastonbury CM, Ha PK et al (2019) Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site. Head Neck 41(6):E82\u2013E85","journal-title":"Head Neck"},{"key":"1620_CR15","doi-asserted-by":"publisher","first-page":"503830","DOI":"10.3389\/fgene.2021.503830","volume":"12","author":"TA Boyle","year":"2021","unstructured":"Boyle TA, Mondal AK, Saeed-Vafa D, Ananth S, Ahluwalia P, Kothapalli R et al (2021) Guideline-Adherent Clinical Validation of a comprehensive 170-Gene DNA\/RNA panel for determination of small variants, Copy Number variations, Splice Variants, and fusions on a next-generation sequencing platform in the CLIA setting. Front Genet 12:503830","journal-title":"Front Genet"},{"issue":"1","key":"1620_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S et al (2017) Standards and guidelines for the interpretation and reporting of sequence variants in Cancer: a Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn JMD 19(1):4\u201323","journal-title":"J Mol Diagn JMD"},{"issue":"5","key":"1620_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","volume":"142","author":"JS Lewis","year":"2018","unstructured":"Lewis JS, Beadle B, Bishop JA, Chernock RD, Colasacco C, Lacchetti C et al (2018) Human papillomavirus testing in Head and Neck carcinomas: Guideline from the College of American Pathologists. Arch Pathol Lab Med 142(5):559\u2013597","journal-title":"Arch Pathol Lab Med"},{"key":"1620_CR18","doi-asserted-by":"crossref","unstructured":"L\u00f3pez F, Rodrigo JP, Silver CE, Haigentz M, Bishop JA, Strojan P et al (2016) Cervical lymph node metastases from remote primary tumor sites: Cervical Lymph Node Metastases from a Non-Head and Neck Primary. Eisele D, editor. Head Neck. 38(S1):E2374\u201385","DOI":"10.1002\/hed.24344"},{"issue":"7793","key":"1620_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y et al (2020) The repertoire of mutational signatures in human cancer. Nature 578(7793):94\u2013101","journal-title":"Nature"},{"issue":"7463","key":"1620_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV et al (2013) Signatures of mutational processes in human cancer. Nature 500(7463):415\u2013421","journal-title":"Nature"},{"issue":"5","key":"1620_CR21","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K et al (2012) Mutational processes molding the genomes of 21 breast cancers. Cell 149(5):979\u2013993","journal-title":"Cell"},{"issue":"9","key":"1620_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrg3729","volume":"15","author":"T Helleday","year":"2014","unstructured":"Helleday T, Eshtad S, Nik-Zainal S (2014) Mechanisms underlying mutational signatures in human cancers. Nat Rev Genet 15(9):585\u2013598","journal-title":"Nat Rev Genet"},{"issue":"3","key":"1620_CR23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF00293945","volume":"182","author":"CW Lawrence","year":"1981","unstructured":"Lawrence CW (1981) Are pyrimidine dimers non-instructive lesions? Mol Gen Genet MGG 182(3):511\u2013513","journal-title":"Mol Gen Genet MGG"},{"issue":"1","key":"1620_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0022-2836(85)90026-9","volume":"182","author":"JH Miller","year":"1985","unstructured":"Miller JH (1985) Mutagenic specificity of ultraviolet light. J Mol Biol 182(1):45\u201365","journal-title":"J Mol Biol"},{"issue":"24","key":"1620_CR25","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.1073\/pnas.84.24.9103","volume":"84","author":"EA Drobetsky","year":"1987","unstructured":"Drobetsky EA, Grosovsky AJ, Glickman BW (1987) The specificity of UV-induced mutations at an endogenous locus in mammalian cells. Proc Natl Acad Sci U S A 84(24):9103\u20139107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1620_CR26","doi-asserted-by":"crossref","unstructured":"Wikonkal NM, Brash DE (1999) Ultraviolet radiation induced signature mutations in photocarcinogenesis. J Investig Dermatol Symp Proc 4(1):6\u201310","DOI":"10.1038\/sj.jidsp.5640173"},{"issue":"14","key":"1620_CR27","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1080\/15384101.2015.1053669","volume":"14","author":"M Schwaederle","year":"2015","unstructured":"Schwaederle M, Elkin SK, Tomson BN, Carter JL, Kurzrock R, Squamousness (2015) Next-generation sequencing reveals shared molecular features across squamous tumor types. Cell Cycle 14(14):2355\u20132361","journal-title":"Cell Cycle"},{"key":"1620_CR28","doi-asserted-by":"publisher","first-page":"1218404","DOI":"10.3389\/fmed.2023.1218404","volume":"10","author":"AD King","year":"2023","unstructured":"King AD, Deirawan H, Klein PA, Dasgeb B, Dumur CI, Mehregan DR (2023) Next-generation sequencing in dermatology. Front Med (Lausanne) 10:1218404","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"1620_CR29","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/annonc\/mdv109","volume":"26","author":"CH Chung","year":"2015","unstructured":"Chung CH, Guthrie VB, Masica DL, Tokheim C, Kang H, Richmon J, Agrawal N, Fakhry C, Quon H, Subramaniam RM, Zuo Z, Seiwert T, Chalmers ZR, Frampton GM, Ali SM, Yelensky R, Stephens PJ, Miller VA, Karchin R, Bishop JA (2015) Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing. Ann Oncol 26(6):1216\u20131223","journal-title":"Ann Oncol"},{"issue":"7536","key":"1620_CR30","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"Cancer Genome Atlas Network","year":"2015","unstructured":"Cancer Genome Atlas Network (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517(7536):576\u2013582","journal-title":"Nature"},{"issue":"8","key":"1620_CR31","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/cncr.29901","volume":"122","author":"LJ McDowell","year":"2016","unstructured":"McDowell LJ, Young RJ, Johnston ML, Tan TJ, Kleid S, Liu CS et al (2016) p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: no association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary. Cancer 122(8):1201\u20131208","journal-title":"Cancer"},{"issue":"5","key":"1620_CR32","first-page":"494","volume":"49","author":"L Satgunaseelan","year":"2017","unstructured":"Satgunaseelan L, Chia N, Suh H, Virk S, Ashford B, Lum T et al (2017) p16 expression in cutaneous squamous cell carcinoma of the head and neck is not associated with integration of high risk HPV DNA or prognosis. Pathol (Phila) 49(5):494\u2013498","journal-title":"Pathol (Phila)"},{"issue":"1","key":"1620_CR33","first-page":"51","volume":"2","author":"JK Stephen","year":"2013","unstructured":"Stephen JK, Divine G, Chen KM, Chitale D, Havard S, Worsham MJ (2013) Significance of p16 in site-specific HPV positive and HPV negative head and Neck squamous cell carcinoma. Cancer Clin Oncol 2(1):51\u201361","journal-title":"Cancer Clin Oncol"},{"issue":"41","key":"1620_CR34","doi-asserted-by":"publisher","first-page":"66569","DOI":"10.18632\/oncotarget.11892","volume":"7","author":"AJ Colebatch","year":"2016","unstructured":"Colebatch AJ, Di Stefano L, Wong SQ, Hannan RD, Waring PM, Dobrovic A et al (2016) Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies. Oncotarget 7(41):66569\u201366585","journal-title":"Oncotarget"},{"issue":"5","key":"1620_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/PAS.0000000000001231","volume":"43","author":"L Sun","year":"2019","unstructured":"Sun L, Cliften PF, Duncavage EJ, Lewis JS, Chernock RD (2019) UV signature mutations reclassify salivary high-grade neuroendocrine carcinomas as Occult Metastatic Cutaneous Merkel Cell Carcinomas. Am J Surg Pathol 43(5):682\u2013687","journal-title":"Am J Surg Pathol"},{"issue":"24","key":"1620_CR36","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1158\/0008-5472.CAN-15-1877","volume":"75","author":"SQ Wong","year":"2015","unstructured":"Wong SQ, Waldeck K, Vergara IA, Schr\u00f6der J, Madore J, Wilmott JS et al (2015) UV-Associated mutations underlie the etiology of MCV-Negative Merkel Cell Carcinomas. Cancer Res 75(24):5228\u20135234","journal-title":"Cancer Res"},{"issue":"1","key":"1620_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s12105-021-01349-x","volume":"16","author":"S Fishbach","year":"2022","unstructured":"Fishbach S, Steinhardt G, Zhen CJ, Puranik R, Segal JP, Cipriani NA (2022) High rates of Ultraviolet-signature mutations in squamous cell carcinomas of the parotid gland and prognostic implications. Head Neck Pathol 16(1):236\u2013247","journal-title":"Head Neck Pathol"},{"issue":"4","key":"1620_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/ajcp\/aqac176","volume":"159","author":"E Hartsough","year":"2023","unstructured":"Hartsough E, Mino-Kenudson M, Lennerz JK, Dias-Santagata D, Hoang MP (2023) Clinical next-generation sequencing panels reveal molecular differences between Merkel Cell Polyomavirus-Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas. Am J Clin Pathol 159(4):395\u2013406","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"1620_CR39","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1007\/s00432-022-04210-y","volume":"149","author":"RP Amorrortu","year":"2023","unstructured":"Amorrortu RP, Zhao Y, Stewart S, Ghia KM, Williams VL, Sondak VK, Tsai KY, Pinilla J, Chavez J, Rollison DE (2023) History of keratinocyte carcinoma and survival after a second primary malignancy: the Moffitt Cancer Center patient experience. J Cancer Res Clin Oncol 149(7):3607\u20133621","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"1620_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11912-021-01120-z","volume":"23","author":"SZ Shalhout","year":"2021","unstructured":"Shalhout SZ, Emerick KS, Kaufman HL, Miller DM (2021) Immunotherapy for non-melanoma skin Cancer. Curr Oncol Rep 23(11):125","journal-title":"Curr Oncol Rep"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-024-01620-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-024-01620-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-024-01620-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:20:07Z","timestamp":1736349607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-024-01620-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1620"],"URL":"https:\/\/doi.org\/10.1007\/s12105-024-01620-x","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]},"assertion":[{"value":"27 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance and compliance with all statutes, directives, and guidelines of an Internal Review Board authorization (IRB# MCC 22705\/ Pro00074465) involving retrospective data analysis, which did not require informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This work was partially presented at the Annual Meeting of the United States and Canadian Academy of Pathology on March 14, 2023 in New Orleans and partial data appears in the conference proceedings.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 note"}}],"article-number":"11"}}